These studies have identified a serial of downstream targets regulating progression of GBM, such as cyclin-dependent kinase 6 (CDK6), epidermal growth factor receptor (EGFR) and enhancer of zeste homolog 2 (EZH2) etc. (7). Here, EZH2 is linked to glioblastoma.